Daniel Woolson's most recent trade in ICU Medical, Inc. was a trade of 2,924 Performance Shares done . Disclosure was reported to the exchange on March 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 2,924 | 0 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 2,924 | 25,897 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.85 per share. | 15 Mar 2026 | 1,295 | 24,602 (0%) | 0% | 125.9 | 162,976 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2026 | 16,147 | 0 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2026 | 16,147 | 28,327 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.00 per share. | 07 Mar 2026 | 6,877 | 21,450 (0%) | 0% | 132 | 907,764 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2026 | 2,153 | 23,603 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2026 | 2,153 | 6,908 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2026 | 1,585 | 12,882 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2026 | 1,585 | 3,170 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.00 per share. | 07 Mar 2026 | 702 | 12,180 (0%) | 0% | 132 | 92,664 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.00 per share. | 07 Mar 2026 | 630 | 22,973 (0%) | 0% | 132 | 83,160 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 152.35 per share. | 25 Nov 2025 | 2,897 | 11,297 (0%) | 0% | 152.4 | 441,364 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,923 | 2,924 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,923 | 15,488 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.45 per share. | 15 Mar 2025 | 1,294 | 14,194 (0%) | 0% | 143.4 | 185,624 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 4,755 | 11,214 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,153 | 9,061 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,153 | 13,518 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 966 | 0 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 966 | 11,832 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.97 per share. | 07 Mar 2025 | 953 | 12,565 (0%) | 0% | 142.0 | 135,297 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.97 per share. | 07 Mar 2025 | 467 | 11,365 (0%) | 0% | 142.0 | 66,300 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 156.25 per share. | 06 Dec 2024 | 2,241 | 10,866 (0%) | 0% | 156.3 | 350,158 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 163.22 per share. | 30 Aug 2024 | 2,502 | 13,107 (0%) | 0% | 163.2 | 408,370 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 2,923 | 16,903 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 2,923 | 5,847 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.08 per share. | 15 Mar 2024 | 1,294 | 15,609 (0%) | 0% | 98.1 | 126,916 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 98.27 per share. | 15 Mar 2024 | 791 | 13,980 (0%) | 0% | 98.3 | 77,733 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 6,459 | 6,459 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 5,792 | 0 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 5,792 | 16,209 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.39 per share. | 07 Mar 2024 | 2,564 | 13,645 (0%) | 0% | 105.4 | 270,220 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,020 | 15,665 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,020 | 0 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 966 | 966 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 966 | 10,843 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.52 per share. | 07 Mar 2024 | 894 | 14,771 (0%) | 0% | 104.5 | 93,441 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.39 per share. | 07 Mar 2024 | 426 | 10,417 (0%) | 0% | 105.4 | 44,896 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 2,020 | 2,020 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 2,020 | 12,500 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 1,417 | 0 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 1,417 | 10,569 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 965 | 1,932 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 965 | 10,908 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.17 per share. | 06 Mar 2023 | 894 | 11,606 (0%) | 0% | 156.2 | 139,616 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.25 per share. | 06 Mar 2023 | 626 | 9,943 (0%) | 0% | 161.3 | 100,943 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.47 per share. | 06 Mar 2023 | 428 | 10,480 (0%) | 0% | 157.5 | 67,397 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 02 Feb 2023 | 1,731 | 9,152 (0%) | 0% | 200 | 346,200 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2022 | 2,897 | 2,897 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 2,020 | 11,777 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 2,020 | 4,040 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,444 | 9,606 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,444 | 0 | - | - | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,418 | 10,385 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,418 | 1,417 | - | - | Performance Shares | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2022 | 894 | 10,883 (0%) | 0% | 0 | Common Stock | |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 242.93 per share. | 06 Mar 2022 | 639 | 8,967 (0%) | 0% | 242.9 | 155,232 | Common Stock |
| ICU Medical Inc | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2022 | 628 | 9,757 (0%) | 0% | 0 | Common Stock |